ISRCTN11193709: SMILE: Strategy for Maintenance of HIV suppression with elvitegravir + darunavir/ritonavir in children (PENTA 17)
- Overall trial status
- Recruitment status
- Not yet recruiting
A phase 2/3 multicentre, open-label, randomised study evaluating safety and antiviral effect of elvitegravir (EVG) administered with darunavir/ritonavir (DRV/r) compared to current standard antiretroviral therapy in HIV-1 infected, virologically suppressed paediatric participants.